| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.5 |